1. Home
  2. AZIO vs BCTX Comparison

AZIO vs BCTX Comparison

Compare AZIO & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AZIO

Azio AI Holdings Inc. Common Stock

N/A

Current Price

$1.58

Market Cap

26.0M

ML Signal

N/A

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.42

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZIO
BCTX
Founded
N/A
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
26.6M
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
AZIO
BCTX
Price
$1.58
$3.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
268.6K
87.3K
Earning Date
N/A
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,939,008.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
217.58
N/A
52 Week Low
$1.23
$0.63
52 Week High
$1.84
$14.68

Technical Indicators

Market Signals
Indicator
AZIO
BCTX
Relative Strength Index (RSI) 45.14 47.64
Support Level $1.32 $3.27
Resistance Level $1.76 $4.51
Average True Range (ATR) 0.20 0.24
MACD 0.01 -0.02
Stochastic Oscillator 62.23 28.85

Price Performance

Historical Comparison
AZIO
BCTX

About AZIO Azio AI Holdings Inc. Common Stock

Azio AI Holdings Inc is a technology infrastructure company focused on developing, owning, and operating artificial intelligence data centers, enterprise GPU compute infrastructure, digital power solutions, and digital asset mining operations. The company operates an integrated AI infrastructure business encompassing AI data center development, the sale and distribution of enterprise GPU systems and server infrastructure, high-performance computing solutions, power hosting, and strategic technology investments, serving enterprise and institutional customers across domestic and international markets.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: